Tatva Chintan Pharma Chem Ltd Share Price

Chemicals

NSE: TATVA Small Cap ISIN: INE0GK401011

As on 18 November 2025 at 23:52 IST

₹1,561.70

-27.00

(-1.70%)

Sell Buy

Over 1 Month

19.50%

Over 6 Months

110.35%

Over 1 Year

92.07%

Over 3 Years

-34.98%

Tatva Chintan Pharma Chem Ltd Summary

Close ₹1,588.70

Open ₹1,489.40

High ₹1,599

Low ₹1,484.20

Volume 5,92,224

Net Turnover (in Cr) ₹93.23

52Wk High ₹1,599

52Wk Low ₹621

52Wk High / Low

621

1,599

Tatva Chintan Pharma Chem Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹3,716.30

EPS (TTM) 5.99

Book Value (BV) 313.31

Div. Yield 0.06 %

P/E (TTM) 265.49

Price/Book Value 5.08

Delivery % 24.23 %

Face Value 10

Key Ratios

PE Ratio 4,849.64

PB Ratio 2.20

EV to Sales 4.40

PEG Ratio -49.04

ROA 0.04

ROE 0.05

Debt-Equity 0.04

Net Profit Margin 0.09

Operating Profit Margin 8.07

Tatva Chintan Pharma Chem Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	385.03	401.01	429.36	442.54	305.56
Total Expenses	377.45	357.44	380.99	338.42	244.86
Profit Before Tax	7.58	43.57	44.78	104.12	60.70
Profit After Tax	5.71	30.35	45.49	95.87	52.26
Operating Profit After Depreciation	8.87	50.10	56.77	108.95	64.90

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	531.45	430.50	196.25	159.61	120.45
Total Non Current Assets	571	520.81	446.61	222.42	130.55
Total Current Assets	265.25	297.91	312.25	435.88	184.25
Total Assets	836.25	818.72	758.86	658.30	314.80
Total Shareholder's Fund	738.82	737.08	514.79	473.09	165.96

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	24.67	98.04	27.78	20.38	19.69
Net Cash Used In Investing Activities	-65.17	-120.62	-101.23	-196.81	-20.66
Net Cash Used In Financing Activities	16.57	30.52	37.80	234.96	-4.71

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	369.98	386.19	408.72	438.44	296.29
Total Expenses	369.51	343.92	366.30	335.17	236.94
Profit Before Tax	0.46	42.27	38.83	103.27	59.35
Profit After Tax	0.33	29.35	40.47	95.99	51.36
Operating Profit After Depreciation	1.75	48.77	50.80	108.22	63.55

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	531.43	430.48	196.22	159.61	120.45
Total Non Current Assets	571.28	521.46	447.25	223.08	131.22
Total Current Assets	251.52	293.61	307.61	453.12	178.46
Total Assets	822.80	815.07	754.86	676.20	309.68
Total Shareholder's Fund	721.31	725.88	504.78	468.88	161.94

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	23.91	102.78	23.73	19.76	18.91
Net Cash Used In Investing Activities	-65.25	-120.52	-101.13	-196.72	-20.61
Net Cash Used In Financing Activities	16.57	30.54	37.82	235.01	-4.72

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	123.52	116.86	107.86	85.90	83.49
Total Expenses	101.30	99.54	98.91	78.84	77.91
Profit Before Tax	13.67	9.10	2.02	-0.24	-1.02
Profit After Tax	9.92	6.65	1.03	0.14	-0.66
Operating Profit after Depreciation	23.23	18.48	9.67	7.10	5.96

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	115.86	109.18	107.65	84	80.96
Total Expenses	94.76	94.11	99.74	78.36	76.36
Profit Before Tax	12.33	7.06	1.56	-1.66	-1.57
Profit After Tax	8.94	5.13	1.10	-1.17	-1.11
Operating Profit after Depreciation	21.89	16.44	9.21	5.68	5.41

Tatva Chintan Pharma Chem Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 1,515.60

S2 1,442.50

S3 1,400.80

Pivot 1,557.30

R1 1,630.40

R2 1,672.10

R3 1,745.20

Moving Average

20 SMA 1,431.25

50 SMA 1,211.88

100 SMA 1,122.51

200 SMA 947.35

Tatva Chintan Pharma Chem Ltd Corporate Actions

Tatva Chintan Pharma Chem Ltd

₹1.0/Share

Announcement Date 12 Sep 2025

Record Date 12 Sep 2025

Div Yield 10%

AGM Date: 29 Sep 2021

AGM 29/09/2021 Pursuant to Regulation 34(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, We hereby enclosed the 25th Annual Report along with the Notice calling 25th Annual General Meeting of the Company scheduled to be held on Wednesday, 29 September, 2021 at 4:00 p.m. (IST) through Video Conferencing (VC) or Other Audio Visual Means (OAVM) (Comprising of Audited Standalone and Consolidated Financial Statements, Directors Report etc.) which is sent through electronic mode to the Members pursuant to the MCA Circular No. 20/2020 dated 5 May, 2020 read with Circular Nos. 14/2020 dated 8 April, 2020, 17/2020 dated 13 April, 2020 and 02/2021 dated 13 January, 2021 and SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2020/79 dated 12 May, 2020 and Circular No. SEBI/HO/CFD/CMD2/CIR/P/2021/11 dated 15 January, 2021 for the financial year ended 31 March, 2021 Pursuant to Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, We hereby submit the copies of newspaper advertisement published in Financial Express (English) and Vadodara Samachar (Gujarati) on 9 September 2021, CORRIGENDUM to Notice cum Annual report (FY 2020-21) and CORRIGENDUM to Book closure for 25th Annual General Meeting of the Company scheduled to be held on Wednesday, 29 September 2021 at 4:00 p.m. (IST) through Video Conferencing (VC) or Other Audio Visual Means (OAVM) Pursuant to provisions of Section 91 of the Companies Act, 2013 read with rules framed thereunder and pursuant to Regulation 42 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, amended, in continuance to our previous communication on the subject as mentioned above, this is to inform you that the REVISED/UPDATED Book Closure dates for the purpose of AGM is to be considered from 21 September 2021 to 29 September 2021 both the days inclusive. (As per BSE Announcement Dated on 8/9/2021) Corrigendum includes corrections in 'Notice cum Annual report' on page 19 to be read as: 'The Register of Members and Share Transfer books shall remain closed from Tuesday, 21 September 2021 to Wednesday, 29 September 2021 (both days inclusive)' Earlier the same was 'The Register of Members and Share Transfer books shall remain closed from Wednesday, 15 September 2021 to Wednesday, 29 September 2021 (both days inclusive)' (As Per BSE Announcement dated on 09.09.2021) Proceedings of 25th Annual General Meeting of Tatva Chintan Pharma Chem Limited held on 29 September 2021 (As Per BSE Announcement Dated on 29/09/2021)

AGM Date: 22 Sep 2022

AGM 22/09/2022 Pursuant to Regulation 30 of the SEBI Listing Regulations, please find enclosed herewith Notice of the 26th AGM of the Members of the Company scheduled to be held on Thursday, 22 September 2022 at 04:00 p.m. (IST) through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM'). The Notice of the 26th AGM of the Company is also available on the website of the Company at www.tatvachintan.com. Kindly take the above information on record. (As Per BSE Announcement Dated on 23.08.2022) Pursuant to provisions of Regulation 30 read with Part A of Schedule III and all other applicable regulations, if any, of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, please find enclosed herewith Proceedings of the 26th Annual General Meeting ('AGM') of the Members of Tatva Chintan Pharma Chem Limited ('the Company') held on Thursday, 22 September 2022 at 04:00 p.m. (IST), through Video Conferencing ('VC') / Other Audio-Visual Means ('OAVM'). The proceedings of 26th Annual General Meeting of the Company shall be made available on the website of the Company at www.tatvachintan.com. (As Per BSE Announcement Dated on 22.09.2022) Pursuant to Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, please find enclosed the voting results of the business transacted at the 26th Annual General Meeting ('AGM') of the members of the Company held on Thursday, 22 September 2022 at 04:00 p.m. (IST) through Video Conference ('VC') / Other Audio Visual Means ('OAVM'). We are also enclosing herewith the Consolidated Report of the Scrutinizer on the remote e-voting and e-voting held during the course of AGM. The above are also being uploaded at the Company''s website at www.tatvachintan.com and on the website of Link Intime India Private Limited, an agency appointed for the purpose of conducting the remote e-voting and e-voting during the process of AGM. (As per BSE Announcement Dated on 23/9/2022)

AGM Date: 22 Sep 2023

Newspaper Advertisement - Disclosure under Regulation 30 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. ('SEBI Listing Regulations') Newspaper Advertisement - Disclosure under Regulation 30, 44 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. ('SEBI Listing Regulations') (As Per BSE Announcement dated on 27.08.2023) Summary of proceedings of the 27th Annual General Meeting held on Friday, 22 September 2023 (As Per BSE Announcement dated on 22.09.2023) Scrutinizer''s Report / Voting Results of 27th Annual General Meeting of the Company held on Friday, 22 September 2023 (As Per BSE Announcement Dated on 23/09/2023)

AGM Date: 20 Sep 2024

AGM 20/09/2024 Summary of proceedings of the 28th Annual General Meeting held on Friday, 20 September 2024 (As Per BSE Announcement Dated on: 20/09/2024) Scrutinizer''s Report / Voting Results of 28th Annual General Meeting of the Company held on Friday, 20 September 2024 (As Per BSE Announcement dated on 21.09.2024)

AGM Date: 26 Sep 2025

AGM 26/09/2025 Notice of the 29th AGM of the Members of the Company scheduled to be held on Friday, 26 September 2025 at 04:00 p.m. (IST) through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM') Summary of proceedings of the 29th Annual General Meeting held on Friday, 26 September 2025. (As Per BSE Announcement Dated on:26.09.2025) Scrutinizer''s Report / Voting Results of 29th Annual General Meeting of the Company held on Friday, 26 September 2025. (As Per BSE Announcement Dated on:27.09.2025)

Tatva Chintan Pharma Chem Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Pidilite Industries Ltd	₹1,476.40	₹1,50,255.30
SRF Ltd	₹2,831.80	₹83,941.58
Linde India Ltd	₹5,740.70	₹48,956.69
Gujarat Fluorochemicals Ltd	₹3,591.30	₹39,450.43
Godrej Industries Ltd	₹1,075.60	₹36,226.55

Tatva Chintan Pharma Chem Ltd Top Mutal Funds Invested

Fund Name	AUM
ICICI Pru MNC Fund	1.38%
Nippon India ELSS Tax Saver Fund	0.49%
ICICI Pru Commodities Fund	0.25%
ICICI Pru Smallcap Fund	0.13%
Motilal Oswal BSE 1000 Index Fund	0%

Tatva Chintan Pharma Chem Ltd News

Tatva Chintan Pharma drops on profit booking

Tatva Chintan Pharma Chem tumbled 4% to Rs 1351.50 as investors booked profits following a steep uptrend in the counter.

23 Oct 2025, 09:44 am

Tatva Chintan Pharma Chem to convene board meeting

On 31 October 2025

18 Oct 2025, 11:02 am

Tatva Chintan Pharma Chem to hold AGM

On 26 September 2025

28 Aug 2025, 01:45 pm

Tatva Chintan Pharma Chem Ltd leads gainers in 'B' group

Omax Autos Ltd, Mirza International Ltd, Kellton Tech Solutions Ltd and Tainwala Chemicals & Plastics (India) Ltd are among the other gainers in the BSE's 'B' group today, 25 July 2025.

25 Jul 2025, 12:15 pm

Tatva Chintan Pharma Chem schedules board meeting

On 24 July 2025

18 Jul 2025, 10:11 am

Tatva Chintan Pharma Chem Ltd Stock Analysis

Annual revenue for Tatva Chintan Pharma Chem Ltd decreased by 4.20% to ₹369.98 crore in FY 2025 from ₹386.19 crore in FY 2024.
Annual Net Profit for Tatva Chintan Pharma Chem Ltd decreased by 98.89% to ₹0.33 crore in FY 2025 from ₹29.35 crore in FY 2024.
Promoter Shareholding in Tatva Chintan Pharma Chem Ltd remains unchanged by 0.00% in the most recent quarter, from 72.02% in June 2025 to 72.02% in September 2025.
Tatva Chintan Pharma Chem Ltd delivered a 1-year return of 92.07% compared to the Nifty 50, which provided a return of 10.91% as of the last trading session.
Tatva Chintan Pharma Chem Ltd share price moved down by 1.70% from its previous close of INR ₹1,588.70. The latest Tatva Chintan Pharma Chem Ltd share price is INR ₹1,561.70.
Tatva Chintan Pharma Chem Ltd share price today has been at a low of 1,553.30 and a high of 1,610. Over the past 52 weeks, the Tatva Chintan Pharma Chem Ltd share price has seen a low of 621 and a high of 1,610.